Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 15/20 | 0.55 |
| ▸ | FLT3 | P36888 | 3/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4723636 | 0.91 | GPR119 (0.62) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4719749 | 0.88 | GPR119 (0.45) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL388449 | 0.88 | GPR119 (0.70) | GPR119CYP2C9KCNH2 | |
| SCHEMBL4719420 | 0.85 | GPR119 (0.61) | GPR119FLT3CDK2CDK6CYP2C9 | |
| SCHEMBL4721651 | 0.84 | GPR119 (0.60) | GPR119FLT3CDK2CDK6CYP2C9 | |
| SCHEMBL4718883 | 0.84 | GPR119 (0.53) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4718845 | 0.83 | GPR119 (0.63) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4720771 | 0.83 | GPR119 (0.48) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4719070 | 0.83 | GPR119 (0.53) | GPR119ACACB | |
| SCHEMBL13685341 | 0.83 | GPR119 (0.53) | GPR119FLT3CDK2CDK6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756084-B1 | SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2008-11-26 | — | — | EP | claimed |